Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic Control
NCT01013662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69
Last updated 2011-08-04
Summary
Study of the lipid metabolism under glycemic control in septic patients who got an university 14 bed ICU.
Hypothesis: establish a relationship between lipid metabolism alterations and glycemic control or infusion of exogenous insulin
Conditions
- Septic Shock
- Sepsis
Interventions
- PROCEDURE
-
glycemic control
exogenous insulin
Sponsors & Collaborators
-
University of Sao Paulo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
More Related Trials
-
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
NCT02519699 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.
NCT05572060 ·Status: UNKNOWN ·Phase: NA
-
Mortality Due to Septic Shock Associated With Thrombocytopenia
NCT03617965 ·Status: UNKNOWN
-
The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock
NCT02566460 ·Status: COMPLETED ·Phase: NA
-
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 ·Status: UNKNOWN
-
Septic Shock em Steroids
NCT01047670 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock
NCT01304680 ·Status: UNKNOWN
-
Amino Acids Expression Profiling of Patients With Sepsis
NCT01818830 ·Status: UNKNOWN
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198 ·Status: NOT_YET_RECRUITING
-
Expression of Protein Tyrosine Phosphatase 1B (PTP1B) and Body Composition Modification in Patients With Septic Shock
NCT03189355 ·Status: COMPLETED ·Phase: NA
-
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
NCT06338124 ·Status: RECRUITING
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
Temporal Changes of Lactate in CLASSIC Patients
NCT05629780 ·Status: COMPLETED ·Phase: NA
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock
NCT04398069 ·Status: UNKNOWN ·Phase: NA
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Glycocalyx and Microcirculation in Sepsis
NCT03960307 ·Status: COMPLETED
-
Assessing Nutritional Status in Patients With Sepsis
NCT03906266 ·Status: COMPLETED ·Phase: NA
-
Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
NCT05833607 ·Status: UNKNOWN
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring
NCT00407823 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN